This is the authors' abstract. We don't add key points for this paper.
MSG-treated SHR presented all metabolic syndrome characteristics, as well as reduced GLUT4 content, which must play a key role in the impaired glycemic homeostasis of the metabolic syndrome.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Leguisamo et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: